TI
ORTX

Trexquant Investment’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Trexquant Investment’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,901
Closed -$201K – 1602
2020
Q3 		$201K Sell
4,901
-711
-13% -$36.8K 0.01% 1081
2020
Q2 		$337K Buy
+5,612
New +$514K 0.02% 820
2020
Q1 		– Sell
-1,095
Closed -$151K – 1498
2019
Q4 		$151K Buy
+1,095
New +$133K 0.01% 954

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Trexquant Investment's ORTX Position: Q4 2020 in Review

Trexquant Investment sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2020, closing a stake of 4,901 shares — an estimated $201K sold.

Trexquant Investment first reported a position in ORTX in Q4 2019 and held it in 3 quarters. The position peaked at $337K in Q2 2020. 77 funds tracked by Wall St. Rank hold ORTX as of Q4 2020.

  • Trexquant Investment reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Trexquant Investment sold 4,901 Orchard Therapeutics plc American Depositary Shares shares in Q4 2020, an estimated $201K.
  • Trexquant Investment first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 3 quarters.
  • Trexquant Investment's Orchard Therapeutics plc American Depositary Shares position peaked at $337K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2020.

Based on Trexquant Investment's 13F filing for Q4 2020, filed 11 Feb 2021.